Get the Stockscreener App
4.57
1.56%
0.07
Pre-market:
5.33
0.76
+16.63%
Pepgen Inc stock is traded at $4.57, with a volume of 509.52K.
It is up +1.56% in the last 24 hours and up +71.80% over the past month.
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.
See More
Previous Close:
$4.50
Open:
$4.55
24h Volume:
509.52K
Relative Volume:
0.19
Market Cap:
$149.89M
Revenue:
-
Net Income/Loss:
$-87.23M
P/E Ratio:
-1.5387
EPS:
-2.97
Net Cash Flow:
$-82.77M
1W Performance:
-6.54%
1M Performance:
+71.80%
6M Performance:
+172.02%
1Y Performance:
-44.47%
1-Day Range:
$4.4483
$4.66
1-Week Range:
$4.36
$5.11
52-Week Range:
$0.8801
$8.33
Pepgen Inc Stock (PEPG) Company Profile
Name
Pepgen Inc
Sector
Industry
Phone
703-456-8000
Address
1 MARINA PARK DRIVE, SUITE 900, BOSTON
Compare PEPG with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PEPG
Pepgen Inc
|
4.57 | 309.32M | 0 | -87.23M | -82.77M | -2.97 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.39 | 108.36B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
463.43 | 60.82B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
577.95 | 61.02B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
817.32 | 50.01B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
310.81 | 34.05B | 4.56B | -176.77M | 225.30M | -1.7177 |
Pepgen Inc Stock (PEPG) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-09-25 | Initiated | Guggenheim | Buy |
| Dec-16-24 | Downgrade | BofA Securities | Neutral → Underperform |
| Jul-31-24 | Downgrade | BofA Securities | Buy → Neutral |
| Dec-21-22 | Initiated | H.C. Wainwright | Buy |
Pepgen Inc Stock (PEPG) Latest News
Detecting price anomalies in PepGen Inc. with AIMarket Growth Summary & Consistent Profit Focused Trading Strategies - newser.com
Is PepGen Inc. stock trading near support levelsShare Buyback & Verified Momentum Stock Watchlist - newser.com
Using flow based indicators on PepGen Inc.Global Markets & AI Driven Price Predictions - newser.com
Will PepGen Inc. stock see insider buyingTrade Risk Summary & Free Growth Oriented Trading Recommendations - newser.com
What risks investors should watch in PepGen Inc. stockInsider Selling & Long-Term Capital Growth Ideas - newser.com
Will PepGen Inc. stock sustain high P E ratiosWeekly Market Outlook & Fast Exit and Entry Trade Guides - newser.com
Bronstein, Gewirtz & Grossman, LLC Encourages PepGen Inc. (PEPG) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
BofA Lifts PepGen (PEPG) PT to $3 on Positive DM1 Data Despite Underperform Rating - Insider Monkey
PepGen Inc. (PEPG) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
What analysts say about PepGen Inc stockEconomic Indicators Overview & Free Grow Wealth With Picks - earlytimes.in
Can momentum traders help lift PepGen Inc.July 2025 Selloffs & Safe Entry Momentum Tips - newser.com
Is PepGen Inc. stock poised for growth2025 Market WrapUp & Daily Price Action Insights - newser.com
How to build a custom watchlist for PepGen Inc.July 2025 Summary & Free Safe Entry Trade Signal Reports - newser.com
What technical models suggest about PepGen Inc.’s comebackCEO Change & Fast Momentum Stock Entry Tips - newser.com
Pepgen Inc Stock (PEPG) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.11%
0.29%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):